Cargando…
Development of Rheumatoid Arthritis During Anti-Interleukin-5 Therapy in a Patient with Refractory Chronic Eosinophilic Pneumonia
PURPOSE: To report the case of a patient with refractory chronic eosinophilic pneumonia who developed rheumatoid arthritis during anti-interleukin (IL)-5 therapy. CASE REPORT: The case of a 66-year-old male ex-smoker with allergic rhinitis who had dyspnea and chronic cough for 6 months and who was u...
Autores principales: | Kawabata, Hiroki, Satoh, Minoru, Yatera, Kazuhiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8631983/ https://www.ncbi.nlm.nih.gov/pubmed/34858033 http://dx.doi.org/10.2147/JAA.S342993 |
Ejemplares similares
-
Immune checkpoint inhibitors‐induced eosinophilic pneumonia: A case report
por: Hara, Kanako, et al.
Publicado: (2021) -
Spontaneous Improvement of Interstitial Pneumonia with Autoimmune Features
por: Oda, Keishi, et al.
Publicado: (2017) -
Repetitive Aspiration Pneumonia Caused by Basilar Impression
por: Kawabata, Hiroki, et al.
Publicado: (2018) -
Anti‐interleukin 5 antibody is effective for not only severe asthma and eosinophilic pneumonia but also eosinophilic bronchiolitis
por: Tomyo, Fuminori, et al.
Publicado: (2018) -
Anti-IL-5 Agents for the Treatment of Idiopathic Chronic Eosinophilic Pneumonia: A Case Series
por: Tashiro, Hiroki, et al.
Publicado: (2022)